Jérôme Galon is a French biologist. He is Director of Research of Exceptional Class (DRCE) at ''Institut National de la Santé et de la Recherche Médicale'' (INSERM). He is also an entrepreneur and co-founder of HalioDx.
Provided by Wikipedia
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
by Locke, Frederick (Author)
, Filosto, Simone (Author)
, Chou, Justin (Author)
, Vardhanabhuti, Saran (Author)
, Perbost, Regis (Author)
, Dreger, Peter (Author)
, Hill, Brian T. (Author)
, Lee, Catherine (Author)
, Zinzani, Pier L. (Author)
, Kröger, Nicolaus (Author)
, López-Guillermo, Armando (Author)
, Greinix, Hildegard (Author)
, Zhang, Wangshu (Author)
, Tiwari, Gayatri (Author)
, Budka, Justin (Author)
, Marincola, Francesco M. (Author)
, To, Christina (Author)
, Mattie, Mike (Author)
, Schupp, Marco (Author)
, Cheng, Paul (Author)
, Bot, Adrian (Author)
, Shen, Rhine (Author)
, Bedognetti, Davide (Author)
, Miao, Harry (Author)
, Galon, Jérôme (Author)
,
